Results 221 to 230 of about 44,865 (239)

Mutated BRAF V600E

2016
openaire   +1 more source

BRAF targeted therapy changes the treatment paradigm in melanoma

Nature Reviews Clinical Oncology, 2011
Antoni Ribas
exaly  

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

Nature Reviews Cancer, 2014
Matthew Holderfield, Frank McCormick, Martin McMahon   +2 more
exaly  

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

New England Journal of Medicine, 2014
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly  

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

New England Journal of Medicine, 2012
Keith T Flaherty, Adil I Daud, Jonathan Cebon   +2 more
exaly  

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Lancet, The, 2012
Axel Hauschild, Jean-Jacques Grob, Ralf Gutzmer   +2 more
exaly  

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

New England Journal of Medicine, 2011
Paul B Chapman, Caroline Robert, James Larkin   +2 more
exaly  

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Cancer Cell, 2010
Jessie Villanueva, Adina Vultur, Damien Kee   +2 more
exaly  

Mutation in BRAF V600E-Reply.

JAMA oncology, 2019
Frank A, Sinicrope, Qian, Shi, Steven R, Alberts   +2 more
openaire   +1 more source

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

Cell, 2010
Steven R Whittaker, Nathalie Dhomen, Richard Marais   +2 more
exaly